BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Pembrolizumab
1
Autoimmune diabetes from pembrolizumab: A case report and review of literature
11/22/2023 4:14:47 AM | Browse: 64 | Download: 120
2
Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report
1/5/2023 3:12:10 AM | Browse: 157 | Download: 419
3
Immune checkpoint inhibitor-associated arthritis in advanced pulmonary adenocarcinoma: A case report
9/29/2022 9:17:29 AM | Browse: 203 | Download: 700
4
Pembrolizumab-induced Stevens-Johnson syndrome in advanced squamous cell carcinoma of the lung: A case report and review of literature
6/17/2022 3:19:26 AM | Browse: 247 | Download: 691
5
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
1/30/2021 10:10:27 AM | Browse: 407 | Download: 991
6
Management of pembrolizumab-induced steroid refractory mucositis with infliximab: A case report
9/22/2020 3:17:13 AM | Browse: 603 | Download: 924
7
Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report
7/7/2020 3:43:52 AM | Browse: 703 | Download: 1045
8
Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review
1/16/2020 7:58:40 AM | Browse: 750 | Download: 1099
9
Pembrolizumab - emerging treatment of pulmonary sarcomatoid carcinoma: A case report
1/7/2020 1:54:39 AM | Browse: 669 | Download: 876
10
Targeted therapy or immunotherapy? Optimal treatment in hepatocellular carcinoma
5/15/2018 7:28:22 AM | Browse: 1024 | Download: 1234
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345